ResMed | RMD - Assets

Stock Price
219.85
Daily Change
0.34 0.15%
Monthly
-2.85%
Yearly
-6.80%
Q2 Forecast
215.15

ResMed reported $8.5B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Ansell USD 3.33B 3.2M Dec/2025
Artivion USD 884.8M 27.13M Dec/2025
AtriCure USD 654.18M 18.74M Dec/2025
Baxter International USD 20.06B 1.01B Dec/2025
Cochlear AUD 2.79B 31.3M Dec/2025
Cooper Companies USD 12.42B 29.4M Dec/2025
CSL USD 37.9B 1.5B Dec/2025
Dexcom USD 6.34B 1.16B Dec/2025
Edwards Lifesciences USD 13.7B 425M Dec/2025
Fisher Paykel Healthcare NZD 2.63B 80.5M Dec/2025
Globus Medical USD 5.3B 207.12M Dec/2025
Haemonetics USD 2.49B 48.73M Dec/2025
Idexx Laboratories USD 3.35B 35.95M Dec/2025
Inogen USD 307.01M 5.03M Sep/2025
Insulet USD 3.19B 161.1M Dec/2025
Integra LifeSciences USD 3.6B 44.45M Dec/2025
Intuitive Surgical USD 20.11B 347.7M Mar/2026
Masimo USD 1.7B 118.6M Dec/2025
Medtronic USD 91.48B 139M Dec/2025
Philips EUR 26.94B 605M Dec/2025
Ramsay Health Care AUD 21.7B 777.8M Dec/2025
ResMed USD 8.5B 195.02M Dec/2025
Sigma Healthcare AUD 8.29B 6.91B Dec/2025
Sonic Healthcare AUD 15.38B 550.57M Dec/2024
Steris USD 10.59B 180.7M Dec/2025
Teleflex USD 6.95B 924.7M Dec/2025
Thermo Fisher Scientific USD 113.28B 2.94B Mar/2026